SCLC ClinicalImpact: New Tools and Expert Guidance for Integrating Immunotherapies

Get expert insights on the optimal integration of immunotherapies in the treatment of small-cell lung cancer with expert-authored commentaries a series of 10 brief interactive videos with downloadable slidesets and a new Interactive Decision Support Tool with expert recommendations individualized to your specific patient scenarios.

Share

Program Content

Activities

Frontline IO + CT in ES-SCLC
My Take on Frontline Chemoimmunotherapy for Extensive-Stage Small-Cell Lung Cancer
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: October 13, 2020

Expires: October 12, 2021

SCLC: WCLC 2020
Key Studies in Small-Cell Lung Cancer From the 2020 World Conference on Lung Cancer
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: March 01, 2021

Expires: February 28, 2022

ES-SCLC Online Tool
An Interactive Treatment Decision Support Tool for Extensive-Stage SCLC
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: May 26, 2021

Expires: May 25, 2022

Activities

LS-SCLC Management
Management of Limited-Stage SCLC
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: November 30, 2020

Expires: November 29, 2021

IO Rationale for ES-SCLC
Rationale for Using Immunotherapy in the Treatment of ES-SCLC
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: December 01, 2020

Expires: November 30, 2021

First-line IO for ES-SCLC
Overview of Immunotherapy Options for Treatment-Naive ES-SCLC
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: December 01, 2020

Expires: November 30, 2021

Relapsed ES-SCLC
Overview of Therapeutic Options for Relapsed ES-SCLC
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: December 01, 2020

Expires: November 30, 2021

Case: Frontline ES-SCLC
Case Discussion: Newly Diagnosed ES-SCLC
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: December 09, 2020

Expires: December 08, 2021

Biomarkers for IO in SCLC
Biomarkers for Immunotherapy in SCLC: Where Are We and Where Are We Going?
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: February 01, 2021

Expires: January 31, 2022

Radiation for ES-SCLC
Role of Radiation Therapy in the Management of ES-SCLC
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: February 02, 2021

Expires: February 01, 2022

IO Trials in SCLC
Key Clinical Trials of Immunotherapy in SCLC
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: February 02, 2021

Expires: February 01, 2022

Case: Managing irAEs
Case Discussion: Management of Immune-Related AEs
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: February 05, 2021

Expires: February 04, 2022

Case: Relapsed ES-SCLC
Case Discussion: Relapsed ES-SCLC
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: February 05, 2021

Expires: February 04, 2022

Activities

ES-SCLC Tool
Interactive Decision Support Tool: Expert Guidance on Treatment Selection for Patients With ES-SCLC
Tool
Congratulations: You achieved a completion on 04/09/2022

Released: May 24, 2021

Expires: May 23, 2022

Activities

LS-SCLC Management
Management of Limited-Stage SCLC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 01, 2020

Expires: November 30, 2021

Firstline IO for ES-SCLC
Overview of Immunotherapy Options for Treatment-Naive ES-SCLC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 01, 2020

Expires: November 30, 2021

Tx for Relapsed ES-SCLC
Overview of Therapeutic Options for Relapsed ES-SCLC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 01, 2020

Expires: November 30, 2021

Rationale for IO in ES-SCLC
Rationale for Using Immunotherapy in the Treatment of ES-SCLC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 01, 2020

Expires: November 30, 2021

Case: Frontline ES-SCLC
Case Discussion: Newly Diagnosed ES-SCLC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 09, 2020

Expires: December 08, 2021

IO Biomarkers
Biomarkers for Immunotherapy in SCLC: Where Are We and Where Are We Going?
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 01, 2021

Expires: January 31, 2022

Radiation for ES-SCLC
Role of Radiation Therapy in the Management of ES-SCLC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 02, 2021

Expires: February 01, 2022

SCLC IO Trials
Key Ongoing Clinical Trials of Immunotherapy in SCLC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 02, 2021

Expires: February 01, 2022

Case: irAE Management
Case Discussion: Management of Immune-Related AEs
Case Challenge
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 05, 2021

Expires: February 04, 2022

Case: Relapsed ES-SCLC
Case Discussion: Relapsed ES-SCLC
Case Challenge
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 05, 2021

Expires: February 04, 2022

Faculty

cover img faculity

Anne Chiang, MD, PhD

Associate Professor
Yale University School of Medicine
Deputy Chief Medical Officer
Chief Network Officer
Smilow Cancer Hopsital
New Haven, Connecticut

cover img faculity

Nicolas Girard, MD, PhD

Professor
Université Paris-Saclay
Head of the Thorax Institute Curie-Montsouris
Institut Curie
Paris, France

cover img faculity

Benjamin Levy, MD

Associate Professor
Johns Hopkins School of Medicine
Baltimore, Maryland

cover img faculity

Taofeek K. Owonikoko, MD, PhD

Professor
Department of Hematology and Medical Oncology
Co-Leader, Thoracic Oncology
Emory University
Atlanta, Georgia

cover img faculity

Mark A. Socinski, MD

Director, Lung Cancer Section of the Division of Hematology/Oncology
Co-Director, UPMC Center for Excellence in Lung Cancer
Co-Director, Lung and Thoracic Malignancies Program
University of Pittsburgh Cancer Institute
University of Pittsburgh
Pittsburgh, Pennsylvania

cover img faculity

Lauren A. Byers, MD

Associate Professor
Thoracic/Head and Neck Medical Oncology
University of Texas MD Anderson Cancer Center
Houston, Texas

cover img faculity

Christine L. Hann, MD, PhD

Associate Professor of Oncology
The Sidney Kimmel Comprehensive Cancer Center
Johns Hopkins University School of Medicine
Baltimore, Maryland

cover img faculity

Stephen Liu, MD

Assistant Professor of Medicine
Department of Medical Oncology
Lombardi Comprehensive Cancer Center
Georgetown University
Washington, DC

cover img faculity

Thomas Stinchcombe, MD

Medical Oncologist
Thoracic Oncology Program
Duke University Medical Center
Durham, North Carolina

Provided by

ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

Merck Sharp & Dohme Corp.